Endocrinology Medical News about cancer mortality in men;metabolic syndrome

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

3. Rapid correction of low vitamin D status in nursing home residents

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Metabolic syndrome and risk of cancer mortality in men
European Journal of Cancer, 06/15/09

Jaggers JR et al. - Data show that metabolic syndrome (MetS) is associated with an increased risk of all-cause cancer mortality in men, implying that successful interventions should be identified to attenuate the negative effects of MetS.

Methods

Aim was to examine the association between MetS and all-cancer mortality in men
Subjects: 33,230 men aged 20-88 yrs who were enrolled in the Aerobics Centre Longitudinal Study and were free of known cancer at the baseline

Results

At baseline 28% of all the participants had MetS
During an average of 14 yrs f/u, there were a total of 685 deaths due to cancer
MetS at baseline was associated with a 56% greater age-adjusted risk in cancer mortality

<< Previous
Pharmacotherapy for the Obese Patient

Next >>
Apolipoprotein B but not low-density lipoprotein cholesterol is...